Pharmacokinetics of 2 Novel Formulations of Modified‐Release Oral Testosterone Alone and With Finasteride in Normal Men With Experimental Hypogonadism
C. N. Snyder(University of Washington), John K. Amory(University of Washington), Mara Y. Roth(University of Washington), Richard V. Clark(Research Triangle Park Foundation), Ralph B. Caricofe(Research Triangle Park Foundation), Stephanie T. Page(University of Washington), William J. Bremner(University of Washington Medical Center), Mark Bush(Research Triangle Park Foundation)
Cited by 10
Related Papers
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
|The Journal of Clinical Endocrinology & Metabolism|2002|1.8k
Advances in Male Contraception
|Endocrine Reviews|2008|1.1k
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|514
Growth Hormone (GH) Replacement Therapy in Adult-Onset GH Deficiency: Effects on Body Composition in Men and Women in a Double-Blind, Randomized, Placebo-Controlled Trial
|The Journal of Clinical Endocrinology & Metabolism|2004|185
Improving the Measurement of Serum Thyroglobulin With Mass Spectrometry
|The Journal of Clinical Endocrinology & Metabolism|2013|117